Richard J Meelia
CIK 1223633 · Chairman, President and CEO · last filed 2021-06-08
Richard J Meelia is a Chairman, President and CEO who has filed 67 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for CFMS, was dated Jun 8, 2021. Across all open-market trades the lifetime net is −$39.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $3.8M across reported positions. 11 SEC filings were submitted jointly with TYCO INTERNATIONAL LTD.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
COV price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
15 HAMPSHIRE STREET
MANSFIELD, MA 02048
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Conformis Inc (CFMS) Delisted | Director | 15,032 | $2.26 | $34.0K | $0 | 6 | 2021-06-08 |
| HAE | Director | 32,050 | $119.78 | $3.84M | -$4.03M | 17 | 2021-02-05 |
| Apollo Endosurgery, Inc. (APEN) Delisted | Director | 56,821 | $10.00 | $568.2K | $250.0K | 3 | 2018-03-02 |
| Apollo Endosurgery, Inc. (LPTN) Delisted | Director | 17,501 | — | — | $0 | 1 | 2016-12-30 |
| Covidien plc (COV) Delisted | Director | 277,312 | — | — | -$35.66M | 38 | 2012-01-11 |
Recent Filings
67 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-06-08 | Conformis Inc (CFMS) Delisted | Grant (A) | +122,223 | $0 | EDGAR |
| 2021-02-05 | HAE | Mixed | — | -$1.03M | EDGAR |
| 2020-07-22 | HAE | Grant (A) | +1,983 | $0 | EDGAR |
| 2020-05-18 | Conformis Inc (CFMS) Delisted | Grant (A) | +111,467 | $0 | EDGAR |
| 2019-11-13 | HAE | Mixed | — | -$477.9K | EDGAR |
| 2019-07-26 | HAE | Grant (A) | +1,460 | $0 | EDGAR |
| 2019-05-08 | Conformis Inc (CFMS) Delisted | Grant (A) | +48,532 | $0 | EDGAR |
| 2018-12-18 | HAE | Mixed | — | -$545.0K | EDGAR |
| 2018-07-30 | HAE | Grant (A) | +1,696 | $0 | EDGAR |
| 2018-05-09 | Conformis Inc (CFMS) Delisted | Grant (A) | +45,648 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.